Assessing the clinical value of faecal bile acid profiling to predict recurrence in primary Clostridioides difficile infection.
Benjamin Harvey MullishLaura Martinez-GiliElena ChekmenevaGonçalo D S CorreiaMatthew R LewisVerena Horneffer-Van Der SluisLauren A RobertsJulie A K McDonaldAlexandros PechlivanisJulian R F WaltersEmma L McClureJulian R MarchesiJessica R AllegrettiPublished in: Alimentary pharmacology & therapeutics (2022)
Gut BA metabolism dynamics differ in primary CDI patients between those developing recurrence and those who do not. Individual BAs show promise as potential novel biomarkers to predict CDI recurrence.